Dimethylformamide Market Size to Hit USD 4.54 Billion by 2035 as Pharmaceutical and Industrial Demand Expands | SNS Insider

The global dimethylformamide (DMF) market is projected to grow from USD 2.79 billion in 2025 to USD 4.54 billion by 2035, at a CAGR of 4.98%. Growth is driven by pharmaceutical API manufacturing expansion in India and China, synthetic leather production in Asia Pacific, and electronics-grade DMF demand. Industrial grade dominates with 58.4% market share, while pharmaceutical grade is the fastest-growing segment at 7.9% CAGR. North America leads with 38.9% revenue share, while Europe faces REACH regulatory compliance pressures.

06/20/2026, 5:30 AM • GlobeNewswire

Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment

The global protein synthesis research market is experiencing accelerating growth driven by increased investment in cell and gene therapy research, rising chronic disease prevalence, and expanding healthcare budgets. North America leads with 42.8% market share, while Asia-Pacific infrastructure expansion presents significant growth opportunities. Key market drivers include strong late-stage therapy pipelines and government support through initiatives like the CHIPS and Science Act.

05/18/2026, 2:33 PM • GlobeNewswire

Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight

The myasthenia gravis market is projected to grow from USD 6 billion in 2025 to over USD 16 billion by 2036, driven by rising diagnosed prevalence, improved diagnostics, and an expanding pipeline of targeted biologic therapies including FcRn inhibitors, complement inhibitors, and CAR-T cell therapies. The market is currently led by argenx and UCB, with numerous emerging candidates in late-stage development expected to significantly accelerate growth.

05/18/2026, 1:00 PM • GlobeNewswire

Organic Semiconductor Market Size to Worth USD 1175.68 Billion by 2035 | Research by SNS Insider

The organic semiconductor market is experiencing significant growth, with projections showing the market reaching USD 301.74 billion by 2035 at a CAGR of 20.05%. Key drivers include advancements in molecular stacking processes improving energy efficiency and brightness in OLED displays. Polymeric organic semiconductors currently dominate with 61.40% market share, while small molecule semiconductors are expected to grow fastest. Asia Pacific leads with 45.40% market share, while North America shows the fastest growth rate at 19.51% CAGR.

05/14/2026, 3:30 AM • GlobeNewswire

[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global cell culture media bags market is valued at USD 1.30 billion in 2025 and is projected to reach USD 2.28 billion by 2035, growing at a CAGR of 5.8%. Growth is driven by increased R&D investments in life sciences, adoption of single-use bioprocessing technologies, and automation trends in biopharmaceutical manufacturing. Single-use bags and EVA materials dominate the market segments, with North America leading in market share and Asia Pacific showing the highest growth rate.

04/29/2026, 12:30 AM • GlobeNewswire

Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight

The generalized myasthenia gravis (gMG) market is experiencing significant growth with 8 promising late-stage drug candidates in development. The gMG market across 7 major markets was valued at USD 5.9 billion in 2025 and is projected to grow at 9.1% CAGR through 2036. Key therapies in development include FcRn inhibitors, complement inhibitors, BTK inhibitors, and innovative CAR-T cell therapies from major pharmaceutical companies.

04/15/2026, 1:00 PM • GlobeNewswire

Zinc Chloride Market Size to Surpass USD 509.55 Million by 2035, Driven by Demand from Batteries, Water Treatment, and Chemical Applications | Report by SNS Insider

The global zinc chloride market is projected to grow from USD 336.16 million in 2025 to USD 509.55 million by 2035, with a CAGR of 4.29%. Growth is driven by demand from dry cell battery production, water treatment applications, and chemical manufacturing. The U.S. market is expected to grow from USD 120.76 million to USD 176.66 million, while Asia Pacific shows the fastest growth at 5.29% CAGR.

04/08/2026, 2:37 AM • GlobeNewswire

[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

The global Pharmaceutical Microbiology QC Testing Market is projected to grow from USD 5.08 billion in 2025 to USD 17.65 billion by 2035, at a CAGR of 13.27%. Growth is driven by increased regulatory oversight, laboratory automation, antimicrobial resistance concerns, and adoption of advanced technologies like AI-enabled molecular platforms and MALDI-TOF mass spectrometry. North America leads with 39.12% market share, while Asia Pacific is expected to grow fastest at 14.33% CAGR.

03/10/2026, 2:00 PM • GlobeNewswire

Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider

The Turner Syndrome market is projected to grow from USD 1.93 billion in 2025 to USD 3.67 billion by 2033, with a CAGR of 8.39%. Growth is driven by advances in genomic diagnostics, increased awareness, government-backed rare disease initiatives, and expanding hormone replacement therapies. North America leads with 37.70% market share, while Asia-Pacific is expected to grow fastest at 9.43% CAGR.

02/18/2026, 5:55 AM • GlobeNewswire

Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'

Sanofi's Board decided not to renew CEO Paul Hudson's mandate, effective February 17, 2026, after six years leading the company. Belén Garijo will take over as CEO on April 29, 2026, with a focus on strengthening R&D productivity and reducing dependence on the eczema drug Dupixent. The leadership change reflects investor pressure over stalled turnaround efforts and vaccine segment challenges.

02/12/2026, 6:28 AM • Benzinga

Cell Therapy Processing Market to Grow 21.4% Annually Through 2030

The global cell therapy processing market is projected to grow from $2.7 billion in 2025 to $7.1 billion by 2030, at a CAGR of 21.4%. Growth is driven by rising demand for advanced cell therapies including CAR-T, increasing R&D investments, expanding clinical trials, and an aging population with chronic diseases. Key challenges include complex manufacturing, regulatory hurdles, and workforce shortages. North America leads the market with the highest share.

02/05/2026, 1:47 PM • GlobeNewswire

Assisted Reproductive Technology Market Report 2026: Opportunities, Competitive Landscape, Trends, Strategies, and Forecasts | Astute Analytica

The global ART market is projected to grow from $30.1 billion in 2024 to $60.7 billion by 2033 at a CAGR of 8.1%, driven by rising infertility prevalence, delayed parenthood, and expanding employer-sponsored fertility benefits. IVF dominates with 90% market share, while Europe leads with 35.80% of the global market. Over 450 Fortune 500 companies now offer fertility benefits, with specialized platforms facilitating over 500,000 virtual consultations in 2024.

01/27/2026, 1:41 PM • GlobeNewswire

Microarrays Market Size to Accumulate Around USD 10.72 Billion by 2033, Driven by Expanding Genomics Research and Advanced Diagnostic Adoption – SNS Insider

The global microarrays market is projected to grow from USD 6.16 billion in 2025 to USD 10.72 billion by 2033, at a CAGR of 7.24%. Growth is driven by increasing adoption of genomics and proteomics research, drug discovery applications, and disease diagnostics. North America dominates with 43% market share, while Asia Pacific emerges as the fastest-growing region with a 9.54% CAGR.

01/26/2026, 11:00 AM • GlobeNewswire

Anatomic Pathology Market Research: Global and Regional Insights, Competition, Forecast and Opportunities, 2025-2033 | Astute Analytica

The global anatomic pathology market is projected to grow from $93.03 billion in 2024 to $224.44 billion by 2033 at a CAGR of 10.28%, driven by rising cancer burden, aging populations, and AI-powered digital pathology adoption. North America leads with over 41% market share, supported by advanced healthcare infrastructure and precision oncology investments. Disease diagnostics account for 74.42% of revenue, with cancer diagnostics representing 60% of biopsy applications globally.

01/22/2026, 1:54 PM • GlobeNewswire

Custom Antibody Market to Reach USD 1,297.65 Million by 2033, Growing Demand for Precision Medicine and Targeted Therapies to Drive the Market – SNS Insider

The global custom antibody market is projected to grow from USD 608.75 million in 2025 to USD 1,297.65 million by 2033, at a CAGR of 9.98%. Growth is driven by increasing demand for precision medicine, targeted therapies, advancements in antibody engineering, and rising investments in biopharmaceutical R&D. However, high development costs and technical challenges may hinder market expansion.

01/20/2026, 11:00 AM • GlobeNewswire